Bausch CEO Papa Will Head Eye Health Biz Under Strategic Review

Bausch Health CEO Joseph Papa will move over to head separate Bausch + Lomb pure-play eye health business and is preparing a team for either a spin-off or initial public offering of the unit in the third quarter, the executive said during a first quarter earning call 4 May. Papa said a sale of the division, which includes consumer health eye drops and dietary supplements, is also possible.

merger and acquisition business concepts, join company on puzzle pieces, 3d rendering

Bausch Health Companies Inc. CEO Joseph Papa told investors 4 May he plans to move with the Bausch & Lomb Inc. eye-care business that is being prepared for a spin-off, initial public offering or sale in the third quarter.

During the firm’s first quarter earnings presentation, Papa said he would continue as CEO of the newly segmented, pure-play eye health B+L business and is already working aggressively to build a

More from Strategy

More from Business